导航
| 股票代码 | 股票名称 | 仓位比例 | 涨跌 | 贡献增长率 |
| 002475 | 立讯精密 | 6.28% | -2.11% | -0.1325% |
| 688596 | 正帆科技 | 6.27% | -0.38% | -0.0238% |
| 300502 | 新易盛 | 5.99% | -0.92% | -0.0551% |
| 002947 | 恒铭达 | 5.54% | -2.81% | -0.1557% |
| 000988 | 华工科技 | 5.23% | -0.62% | -0.0324% |
| 300570 | 太辰光 | 5.10% | -3.17% | -0.1617% |
| 002465 | 海格通信 | 4.54% | -2.15% | -0.0976% |
| 601138 | 工业富联 | 4.18% | -0.08% | -0.0033% |
| 300416 | 苏试试验 | 4.02% | -1.77% | -0.0712% |
| 002463 | 沪电股份 | 4.01% | -0.09% | -0.0036% |
| 重仓股合计:51.16%, 重仓股贡献增长率: -0.7369%, 总持股仓位:91.04%,修正增长率: | ||||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-30 | -0.36% | -1.13% |
| 2024-04-29 | 1.57% | 1.80% |
| 2024-04-26 | 3.89% | 3.49% |
| 2024-04-25 | -0.80% | -0.53% |
| 2024-04-24 | 4.61% | 3.72% |
| 2024-04-23 | 0.76% | 1.12% |
| 2024-04-22 | -1.56% | 1.27% |
| 2024-04-19 | -1.76% | -1.78% |
| 基金名称 | 单位净值 | 增长率 |
| 恒生生物科技ETF | 0.4517 | 4.2951% |
| 华泰柏瑞新经济沪港深混合C | 0.9955 | 4.2362% |
| 嘉实前沿科技沪港深股票C | 1.4025 | 4.0889% |
| 港股医药 | 0.6579 | 3.9601% |
| 港科技50 | 0.7011 | 3.8733% |
| 港股通医药ETF | 0.7660 | 3.8703% |
| 科技HK | 0.6860 | 3.8652% |
| 香港科技 | 0.8177 | 3.8012% |
| 港股医药ETF | 0.5712 | 3.7540% |
| 港股科技ETF | 0.6479 | 3.7190% |
| 基金名称 | 单位净值 | 增长率 |
| 嘉实港股互联网产业核心资产混合C | 0.5756 | 5.7841% |
| 易方达港股通成长混合A | 0.6801 | 4.5230% |
| 易方达港股通成长混合C | 0.6730 | 4.5230% |
| 华泰柏瑞港股通时代机遇混合A | 0.3798 | 3.9562% |
| 华泰柏瑞港股通时代机遇混合C | 0.3730 | 3.9562% |
| 中银港股通医药混合发起A | 0.9289 | 3.7014% |
| 中银港股通医药混合发起C | 0.9274 | 3.7014% |
| 兴全沪港深两年持有混合 | 0.6372 | 3.3401% |
| 中邮沪港深精选混合 | 0.7174 | 3.2805% |
| 德邦港股通成长精选混合A | 0.6624 | 3.1342% |
